A unique force in the pharmaceutical industryMerck Serono combines its complementary expertise in new chemical entities (NCEs) and new biological entities (NBEs) to offer
innovative prescription drugs of either origin.
With comprehensive skills in all areas from research and development to manufacturing, marketing and sales, the division offers
its world-class products in over 150 countries worldwide. Our strategically positioned workforce of 9,000 sales and marketing
employees ensures commercial coverage in the U.S. and Canada, Latin America, Europe, Asia-Pacific and Japan.
We aim to
We will invest resources to ensure support in the following areas
-
Genetic testing to identify responders to therapies
-
Technologies to enhance adherence
-
Nurse programmes to support patients
In the UK
Merck Serono UK are developing a legacy:
‘What we do with our technologies has a direct impact on you and your patients.’